Skip to main content

#Coronavirus Disease Research #References (by AMEDEO, November 29 '25)

 


    BMJ


  1. Analysis of peer reviewers' response to invitations by gender and geographical region: cohort study of manuscripts reviewed at 19 biomedical journals before and during covid-19 pandemic.
    BMJ. 2025;391:r2507.
    PubMed        


    Clin Infect Dis

  2. NGUYEN VAN JC, Pilmis B, El Helali N, Azria E, et al
    Implementing POCT in infectious diseases.
    Clin Infect Dis. 2025 Nov 27:ciaf650. doi: 10.1093.
    PubMed         Abstract available

  3. PANAGIOTOPOULOS AP, Anastassopoulou C, Tsakris A, Ioannidis JPA, et al
    Effective Antivirals in Pandemic Preparedness: Past Mistakes, Future Needs.
    Clin Infect Dis. 2025 Nov 25:ciaf648. doi: 10.1093.
    PubMed         Abstract available


    Int J Infect Dis

  4. HEMPEL H, Xue H, La Shu S, Jain S, et al
    Cancer and COVID-19: A review of Immune Insights and Partnerships to Inform Public Health Strategy.
    Int J Infect Dis. 2025 Nov 24:108252. doi: 10.1016/j.ijid.2025.108252.
    PubMed         Abstract available

  5. A Z, P S, P W, Ac C, et al
    Objective Family Burden of Diabetes Is Associated with Increased Risk of Hospital Diagnosis of COVID-19: A Prospective Cohort Study from the Malmo Diet and Cancer Study.
    Int J Infect Dis. 2025 Nov 22:108241. doi: 10.1016/j.ijid.2025.108241.
    PubMed         Abstract available


    J Virol

  6. CHEN Y, Shi Y, Huang C, Huang H, et al
    Nephropathogenic infectious bronchitis virus induces epithelial-mesenchymal transition of renal tubular epithelial cells through the TGF-beta/p-P38 pathway causing uric acid excretion disorder in chickens.
    J Virol. 2025;99:e0103125.
    PubMed         Abstract available


    Lancet Infect Dis

  7. HAPPLE C, Hoffmann M, Stankov MV, Nehlmeier I, et al
    Effects of LP.8.1-adapted mRNA vaccination on SARS-CoV-2 variant neutralisation.
    Lancet Infect Dis. 2025 Nov 21:S1473-3099(25)00690.
    PubMed        

  8. CHOSIDOW A, Maakaroun-Vermesse Z, Ok V, Delecroix C, et al
    Post-COVID-19 resurgence of Mycoplasma pneumoniae infections in French children (ORIGAMI): a retrospective and prospective multicentre cohort study.
    Lancet Infect Dis. 2025 Nov 19:S1473-3099(25)00598.
    PubMed         Abstract available


    Nature

  9. KU Z, Xie X, Hinton PR, Liu X, et al
    Author Correction: Nasal delivery of an IgM offers broad protection from SARS-CoV-2 variants.
    Nature. 2025 Nov 27. doi: 10.1038/s41586-025-09953.
    PubMed        

Comments

Popular posts from this blog

#Neuroinvasive #Oropouche virus in a patient with #HIV from extra-Amazonian #Brazil

{Excerpt} A novel reassortant Oropouche virus (OROV) lineage (with medium [M], large [L], and small [S] RNA segments : M1L2S2) has driven Brazil's largest and most geographically widespread OROV epidemic , expanding beyond the endemic Amazon basin to establish local transmission across multiple Brazilian states and other previously unaffected Latin American countries . The rapid spread of this lineage underscores its evolutionary potential and reinforces its significance as a public health threat .1 Similar to chikungunya and Zika viruses, expanding arboviruses can exhibit unexpected clinical and epidemiological shifts , including vertical transmissions , neuroinvasive effects, and potentially fatal outcomes.2–4 Although OROV typically causes self-limited febrile illness, accumulating clinical and experimental evidence suggests neurotropic potential .5 This Correspondence describes the first confirmed case of neuroinvasive OROV infection caused by the emergent M1L2S2 lineage in ext...

No evidence of immune #exhaustion after repeated #SARS-CoV-2 #vaccination in vulnerable and healthy populations

Abstract Frequent SARS-CoV-2 vaccination in vulnerable populations has raised concerns that this may contribute to T cell exhaustion , which could negatively affect the quality of immune protection. Herein, we examined the impact of repeated SARS-CoV-2 vaccination on T cell phenotypic and functional exhaustion in frail older adults in long-term care (n = 23), individuals on immunosuppressive drugs (n = 10), and healthy adults (n = 43), in Canada . Spike-specific CD4+ and CD8+ T cell levels did not decline in any cohort following repeated SARS-CoV-2 vaccination, nor did the expression of exhaustion markers on spike-specific or total T cells increase. T cell production of multiple cytokines (i.e. polyfunctionality) in response to the spike protein of SARS-CoV-2 did not decline in any cohort following repeated vaccination. None of the cohorts displayed elevated levels of terminally differentiated T cells following multiple SARS-CoV-2 vaccinations. Thus, repeated SARS-CoV-2 vaccination was...

Chimeric #hemagglutinin and #M2 #mRNA #vaccine for broad #influenza subtype protection

Abstract Since multiple and unpredicted influenza viruses cause seasonal epidemics and even high-risk pandemics , developing a universal influenza vaccine is essential to provide broad protection against various influenza subtypes. Combined with the mRNA lipid nanoparticle-encapsulated (mRNA-LNP) vaccine platform and chimeric immunogen strategy , we developed a novel cocktail mRNA vaccine encoding chimeric HAs (cH5/1-BV, cH7/3) and intact M2 (termed Fluaxe), which confers broad protection against major circulating IAVs and IBVs , as well as highly pathogenic avian influenza . Two-dose intramuscular immunization of Fluaxe in mice elicited cross-reactive neutralizing antibodies , T cell responses, and long-lived immunity, resulting in robust protection against multiple lethal influenza virus infections and severe acute lung injuries . In particular, intramuscular administration stimulated systemic immunity together with a prominent lung tropism of memory cells . Moreover, Fluaxe immuniza...